Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative study of commercially available anti-alpha-synuclein antibodies.

E Croisier1, D Elfant MRes, M Deprez

  • 1Department of Neuropathology, Imperial College London, London, UK.

Neuropathology and Applied Neurobiology
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A challenging case of sporadic melanocytoma of the jugular foramen.

Neuro-Chirurgie·2021
Same author

Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions.

Neuropathology and applied neurobiology·2020
Same author

Using single-cell RNA sequencing to unravel cell lineage relationships in the respiratory tract.

Biochemical Society transactions·2020
Same author

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal.

Virchows Archiv : an international journal of pathology·2019
Same author

Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.

Neuropathology and applied neurobiology·2019
Same author

Respiration resolved imaging with continuous stable state 2D acquisition using linear frequency SWEEP.

Magnetic resonance in medicine·2019

Standardizing alpha-synuclein immunohistochemistry is crucial for diagnosing Parkinson's disease and related disorders. This study identified optimal antibodies and protocols for reliable detection of alpha-synuclein in neuropathology.

Area of Science:

  • Neuropathology
  • Neuroscience
  • Immunohistochemistry

Background:

  • Alpha-synuclein immunohistochemistry is key for diagnosing Parkinson's disease, Dementia with Lewy bodies, and Multiple System Atrophy.
  • Existing protocols lack standardization, leading to variability in diagnostic accuracy.
  • A review of 270 studies revealed only 31% used commercial antibodies, with inconsistent protocols.

Purpose of the Study:

  • To establish a standardized protocol for alpha-synuclein immunohistochemistry in diagnostic neuropathology.
  • To evaluate and compare seven commercial monoclonal antibodies for detecting alpha-synuclein.
  • To determine optimal antigen unmasking methods for each antibody.

Main Methods:

  • Reviewed 242 studies on alpha-synuclein immunohistochemistry in human tissue.

Related Experiment Videos

  • Tested seven commercial monoclonal antibodies on brain tissue from patients with Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and controls.
  • Assessed antibody performance based on immunolabelling intensity in various pathological features and non-specific staining.

    • Main Results:

    • All tested antibodies detected alpha-synuclein inclusions.
    • Significant differences were observed between antibodies, particularly in detecting glial inclusions.
    • Antibodies targeting amino acids 116-131 and 15-123 showed superior performance.

    Conclusions:

    • Standardized protocols are needed for reliable alpha-synuclein detection in alpha-synucleinopathies.
    • Specific antibodies targeting amino acids 116-131 and 15-123 are recommended for routine diagnostic practice.
    • Further optimization of immunohistochemistry protocols will enhance diagnostic accuracy for neurodegenerative diseases.